Drug Regulator Okays Restrictive Use Of Itolizumab To Treat COVID Patients
New Delhi: India’s drug regulator has approved Itolizumab, a drug used to cure skin ailment psoriasis, for “restricted emergency use” to treat COVID-19 patients with moderate to severe acute respiratory distress.
Considering the unmet…